{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:00:57Z","timestamp":1791068457094,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["Productivity Fellowships"],"award-info":[{"award-number":["Productivity Fellowships"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["Productivity Fellowships"],"award-info":[{"award-number":["Productivity Fellowships"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["Productivity Fellowships"],"award-info":[{"award-number":["Productivity Fellowships"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/25118-8"],"award-info":[{"award-number":["2018\/25118-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/25118-8"],"award-info":[{"award-number":["2018\/25118-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006506","name":"Minist\u00e9rio da Sa\u00fade","doi-asserted-by":"publisher","award":["25000.056766\/2015-64"],"award-info":[{"award-number":["25000.056766\/2015-64"]}],"id":[{"id":"10.13039\/501100006506","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-67810-3","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T23:03:13Z","timestamp":1722034993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Functional evaluation of germline TP53 variants identified in Brazilian families at-risk for Li\u2013Fraumeni syndrome"],"prefix":"10.1038","volume":"14","author":[{"given":"Renata B. V.","family":"Abreu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane S.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela N.","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Ashton-Prolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane A. O.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matias E.","family":"Melendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edenir I.","family":"Palmero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,26]]},"reference":[{"key":"67810_CR1","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1126\/science.1978757","volume":"250","author":"D Malkin","year":"1990","unstructured":"Malkin, D. et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250, 1233\u20131238. https:\/\/doi.org\/10.1126\/science.1978757 (1990).","journal-title":"Science"},{"key":"67810_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/CCO.0000000000000423","volume":"30","author":"A Amadou","year":"2018","unstructured":"Amadou, A., Achatz, M. I. W. & Hainaut, P. Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: Temporal phases of Li\u2013Fraumeni syndrome. Curr. Opin. Oncol. 30, 23\u201329. https:\/\/doi.org\/10.1097\/CCO.0000000000000423 (2018).","journal-title":"Curr. Opin. Oncol."},{"key":"67810_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cancergen.2020.09.002","volume":"248\u2013249","author":"C Fortuno","year":"2020","unstructured":"Fortuno, C. et al. Genotype-phenotype correlations among TP53 carriers: Literature review and analysis of probands undergoing multi-gene panel testing and single-gene testing. Cancer Genet. 248\u2013249, 11\u201317. https:\/\/doi.org\/10.1016\/j.cancergen.2020.09.002 (2020).","journal-title":"Cancer Genet."},{"key":"67810_CR4","doi-asserted-by":"publisher","first-page":"3673","DOI":"10.1002\/cncr.30248","volume":"122","author":"PL Mai","year":"2016","unstructured":"Mai, P. L. et al. Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li\u2013Fraumeni syndrome cohort. Cancer 122, 3673\u20133681. https:\/\/doi.org\/10.1002\/cncr.30248 (2016).","journal-title":"Cancer"},{"key":"67810_CR5","unstructured":"Schneider, K., Zelley, K., Nichols, K. E. & Garber (1993) J. in GeneReviews (R) (eds.) M. P. Adam et al."},{"key":"67810_CR6","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/S1470-2045(21)00580-5","volume":"22","author":"KC de Andrade","year":"2021","unstructured":"de Andrade, K. C. et al. Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: An observational cohort study. Lancet Oncol. 22, 1787\u20131798. https:\/\/doi.org\/10.1016\/S1470-2045(21)00580-5 (2021).","journal-title":"Lancet Oncol."},{"key":"67810_CR7","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.6004\/jnccn.2023.0051","volume":"21","author":"MB Daly","year":"2023","unstructured":"Daly, M. B. et al. NCCN Guidelines(R) Insights: Genetic\/Familial high-risk assessment: Breast, ovarian, and pancreatic, version 2.2024. J. Natl. Compr. Cancer Netw. 21, 1000\u20131010. https:\/\/doi.org\/10.6004\/jnccn.2023.0051 (2023).","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"67810_CR8","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s41431-020-0638-4","volume":"28","author":"T Frebourg","year":"2020","unstructured":"Frebourg, T. et al. Guidelines for the Li\u2013Fraumeni and heritable TP53-related cancer syndromes. Eur. J. Hum Genet. 28, 1379\u20131386. https:\/\/doi.org\/10.1038\/s41431-020-0638-4 (2020).","journal-title":"Eur. J. Hum Genet."},{"key":"67810_CR9","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1001\/jamaoncol.2021.4398","volume":"7","author":"CP Kratz","year":"2021","unstructured":"Kratz, C. P. et al. Analysis of the Li\u2013Fraumeni spectrum based on an international germline TP53 variant data set: An international agency for research on cancer TP53 database analysis. JAMA Oncol. 7, 1800\u20131805. https:\/\/doi.org\/10.1001\/jamaoncol.2021.4398 (2021).","journal-title":"JAMA Oncol."},{"key":"67810_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of medical genetics and genomics and the association for molecular pathology. Genet. Med. Offic. J. Am. College Med. Genet. 17, 405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30 (2015).","journal-title":"Genet. Med. Offic. J. Am. College Med. Genet."},{"key":"67810_CR11","doi-asserted-by":"publisher","first-page":"a026187","DOI":"10.1101\/cshperspect.a026187","volume":"7","author":"T Guha","year":"2017","unstructured":"Guha, T. & Malkin, D. Inherited TP53 mutations and the Li\u2013Fraumeni syndrome. Cold Spring Harb Perspect Med. 7, a026187. https:\/\/doi.org\/10.1101\/cshperspect.a026187 (2017).","journal-title":"Cold Spring Harb Perspect Med."},{"key":"67810_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/jmcb\/mjy072","volume":"11","author":"X Zhou","year":"2019","unstructured":"Zhou, X., Hao, Q. & Lu, H. Mutant p53 in cancer therapy-the barrier or the path. J. Mol. Cell Biol. 11, 293\u2013305. https:\/\/doi.org\/10.1093\/jmcb\/mjy072 (2019).","journal-title":"J. Mol. Cell Biol."},{"key":"67810_CR13","doi-asserted-by":"publisher","first-page":"11828","DOI":"10.3390\/ijms222111828","volume":"22","author":"L Carlsen","year":"2021","unstructured":"Carlsen, L. & El-Deiry, W. S. Differential p53-mediated cellular responses to DNA-damaging therapeutic agents. Int. J. Mol. Sci. 22, 11828. https:\/\/doi.org\/10.3390\/ijms222111828 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"67810_CR14","doi-asserted-by":"publisher","first-page":"10883","DOI":"10.3390\/ijms221910883","volume":"22","author":"D Rizzotto","year":"2021","unstructured":"Rizzotto, D., Englmaier, L. & Villunger, A. At a crossroads to cancer: How p53-induced cell fate decisions secure genome integrity. Int. J. Mol. Sci. 22, 10883. https:\/\/doi.org\/10.3390\/ijms221910883 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"67810_CR15","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1101\/gad.340976.120","volume":"34","author":"J Gencel-Augusto","year":"2020","unstructured":"Gencel-Augusto, J. & Lozano, G. p53 tetramerization: at the center of the dominant-negative effect of mutant p53. Genes Dev. 34, 1128\u20131146. https:\/\/doi.org\/10.1101\/gad.340976.120 (2020).","journal-title":"Genes Dev."},{"key":"67810_CR16","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.molcel.2006.05.015","volume":"22","author":"M Kitayner","year":"2006","unstructured":"Kitayner, M. et al. Structural basis of DNA recognition by p53 tetramers. Mol. Cell 22, 741\u2013753. https:\/\/doi.org\/10.1016\/j.molcel.2006.05.015 (2006).","journal-title":"Mol. Cell"},{"key":"67810_CR17","doi-asserted-by":"publisher","first-page":"16176","DOI":"10.1038\/s41598-020-73234-6","volume":"10","author":"E Ly","year":"2020","unstructured":"Ly, E., Kugel, J. F. & Goodrich, J. A. Single molecule studies reveal that p53 tetramers dynamically bind response elements containing one or two half sites. Sci. Rep. 10, 16176. https:\/\/doi.org\/10.1038\/s41598-020-73234-6 (2020).","journal-title":"Sci. Rep."},{"key":"67810_CR18","doi-asserted-by":"publisher","first-page":"a028308","DOI":"10.1101\/cshperspect.a028308","volume":"7","author":"G Chillemi","year":"2017","unstructured":"Chillemi, G. et al. Structural evolution and dynamics of the p53 proteins. Cold Spring Harb Perspect Med. 7, a028308. https:\/\/doi.org\/10.1101\/cshperspect.a028308 (2017).","journal-title":"Cold Spring Harb Perspect Med."},{"key":"67810_CR19","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/s41418-020-00672-0","volume":"28","author":"F Doffe","year":"2021","unstructured":"Doffe, F. et al. Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene. Cell Death Differ. 28, 1477\u20131492. https:\/\/doi.org\/10.1038\/s41418-020-00672-0 (2021).","journal-title":"Cell Death Differ."},{"key":"67810_CR20","doi-asserted-by":"publisher","first-page":"8424","DOI":"10.1073\/pnas.1431692100","volume":"100","author":"S Kato","year":"2003","unstructured":"Kato, S. et al. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc. Nat. Acad. Sci. USA. 100, 8424\u20138429. https:\/\/doi.org\/10.1073\/pnas.1431692100 (2003).","journal-title":"Proc. Nat. Acad. Sci. USA."},{"key":"67810_CR21","doi-asserted-by":"publisher","first-page":"a003921","DOI":"10.1101\/mcs.a003921","volume":"5","author":"EA Quinn","year":"2019","unstructured":"Quinn, E. A. et al. From uncertainty to pathogenicity: Clinical and functional interrogation of a rare TP53 in-frame deletion. Cold Spring Harb Mol Case Stud 5, a003921. https:\/\/doi.org\/10.1101\/mcs.a003921 (2019).","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"67810_CR22","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/humu.22561","volume":"35","author":"T Soussi","year":"2014","unstructured":"Soussi, T., Leroy, B. & Taschner, P. E. Recommendations for analyzing and reporting TP53 gene variants in the high-throughput sequencing era. Human Mutat. 35, 766\u2013778. https:\/\/doi.org\/10.1002\/humu.22561 (2014).","journal-title":"Human Mutat."},{"key":"67810_CR23","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.neo.2015.10.003","volume":"17","author":"LK Mullany","year":"2015","unstructured":"Mullany, L. K. et al. Specific TP53 mutants overrepresented in ovarian cancer impact CNV, TP53 activity, responses to nutlin-3a, and cell survival. Neoplasia 17, 789\u2013803. https:\/\/doi.org\/10.1016\/j.neo.2015.10.003 (2015).","journal-title":"Neoplasia"},{"key":"67810_CR24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10689-019-00140-w","volume":"18","author":"CM Bittar","year":"2019","unstructured":"Bittar, C. M. et al. TP53 variants of uncertain significance: Increasing challenges in variant interpretation and genetic counseling. Fam. Cancer 18, 451\u2013456. https:\/\/doi.org\/10.1007\/s10689-019-00140-w (2019).","journal-title":"Fam. Cancer"},{"key":"67810_CR25","doi-asserted-by":"publisher","first-page":"14259","DOI":"10.1038\/s41598-023-41481-y","volume":"13","author":"H Butz","year":"2023","unstructured":"Butz, H. et al. Challenging interpretation of germline TP53 variants based on the experience of a national comprehensive cancer centre. Sci. Rep. 13, 14259. https:\/\/doi.org\/10.1038\/s41598-023-41481-y (2023).","journal-title":"Sci. Rep."},{"key":"67810_CR26","doi-asserted-by":"publisher","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","volume":"44","author":"MJ Landrum","year":"2016","unstructured":"Landrum, M. J. et al. ClinVar: Public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 44, D862-868. https:\/\/doi.org\/10.1093\/nar\/gkv1222 (2016).","journal-title":"Nucleic Acids Res."},{"key":"67810_CR27","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1038\/onc.2016.502","volume":"36","author":"M Fischer","year":"2017","unstructured":"Fischer, M. Census and evaluation of p53 target genes. Oncogene 36, 3943\u20133956. https:\/\/doi.org\/10.1038\/onc.2016.502 (2017).","journal-title":"Oncogene"},{"key":"67810_CR28","doi-asserted-by":"publisher","first-page":"a026047","DOI":"10.1101\/cshperspect.a026047","volume":"7","author":"N Raj","year":"2017","unstructured":"Raj, N. & Attardi, L. D. The transactivation domains of the p53 protein. Cold Spring Harb Perspect Med. 7, a026047. https:\/\/doi.org\/10.1101\/cshperspect.a026047 (2017).","journal-title":"Cold Spring Harb Perspect Med."},{"key":"67810_CR29","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/cge.13564","volume":"96","author":"P Kharaziha","year":"2019","unstructured":"Kharaziha, P. et al. Functional characterization of novel germline TP53 variants in Swedish families. Clin Genet. 96, 216\u2013225. https:\/\/doi.org\/10.1111\/cge.13564 (2019).","journal-title":"Clin Genet."},{"key":"67810_CR30","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1128\/MCB.01967-06","volume":"27","author":"LE Giono","year":"2007","unstructured":"Giono, L. E. & Manfredi, J. J. Mdm2 is required for inhibition of Cdk2 activity by p21, thereby contributing to p53-dependent cell cycle arrest. Mol. Cell Biol. 27, 4166\u20134178. https:\/\/doi.org\/10.1128\/MCB.01967-06 (2007).","journal-title":"Mol. Cell Biol."},{"key":"67810_CR31","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.4161\/cc.6.12.4313","volume":"6","author":"EV Broude","year":"2007","unstructured":"Broude, E. V. et al. p21 (CDKN1A) is a negative regulator of p53 stability. Cell Cycle 6, 1468\u20131471 (2007).","journal-title":"Cell Cycle"},{"key":"67810_CR32","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1038\/s41418-020-0501-8","volume":"27","author":"P Janus","year":"2020","unstructured":"Janus, P. et al. Pro-death signaling of cytoprotective heat shock factor 1: Upregulation of NOXA leading to apoptosis in heat-sensitive cells. Cell Death Differ. 27, 2280\u20132292. https:\/\/doi.org\/10.1038\/s41418-020-0501-8 (2020).","journal-title":"Cell Death Differ."},{"key":"67810_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11010-010-0514-6","volume":"343","author":"A Ghosh","year":"2010","unstructured":"Ghosh, A., Chen, T. C. & Kapila, Y. L. Anoikis triggers Mdm2-dependent p53 degradation. Mol. Cell Biochem. 343, 201\u2013209. https:\/\/doi.org\/10.1007\/s11010-010-0514-6 (2010).","journal-title":"Mol. Cell Biochem."},{"key":"67810_CR34","doi-asserted-by":"publisher","first-page":"e51116","DOI":"10.1371\/journal.pone.0051116","volume":"7","author":"DS Son","year":"2012","unstructured":"Son, D. S., Kabir, S. M., Dong, Y. L., Lee, E. & Adunyah, S. E. Inhibitory effect of tumor suppressor p53 on proinflammatory chemokine expression in ovarian cancer cells by reducing proteasomal degradation of IkappaB. PLoS One 7, e51116. https:\/\/doi.org\/10.1371\/journal.pone.0051116 (2012).","journal-title":"PLoS One"},{"key":"67810_CR35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrc.2015.2","volume":"16","author":"WP Roos","year":"2016","unstructured":"Roos, W. P., Thomas, A. D. & Kaina, B. DNA damage and the balance between survival and death in cancer biology. Nat. Rev. Cancer 16, 20\u201333. https:\/\/doi.org\/10.1038\/nrc.2015.2 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"67810_CR36","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1093\/jnci\/djy114","volume":"110","author":"NW Fischer","year":"2018","unstructured":"Fischer, N. W., Prodeus, A., Tran, J., Malkin, D. & Gariepy, J. Association between the oligomeric status of p53 and clinical outcomes in Li\u2013Fraumeni syndrome. J. Nat. Cancer Inst. 110, 1418\u20131421. https:\/\/doi.org\/10.1093\/jnci\/djy114 (2018).","journal-title":"J. Nat. Cancer Inst."},{"key":"67810_CR37","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41588-018-0204-y","volume":"50","author":"AO Giacomelli","year":"2018","unstructured":"Giacomelli, A. O. et al. Mutational processes shape the landscape of TP53 mutations in human cancer. Nat. Genet. 50, 1381\u20131387. https:\/\/doi.org\/10.1038\/s41588-018-0204-y (2018).","journal-title":"Nat. Genet."},{"key":"67810_CR38","doi-asserted-by":"publisher","first-page":"14860","DOI":"10.1074\/jbc.RA119.008374","volume":"294","author":"Y Masuda","year":"2019","unstructured":"Masuda, Y. et al. Stepwise multipolyubiquitination of p53 by the E6AP-E6 ubiquitin ligase complex. J. Biol. Chem. 294, 14860\u201314875. https:\/\/doi.org\/10.1074\/jbc.RA119.008374 (2019).","journal-title":"J. Biol. Chem."},{"key":"67810_CR39","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1001\/jamaoncol.2017.1350","volume":"3","author":"PL Mai","year":"2017","unstructured":"Mai, P. L. et al. Prevalence of cancer at baseline screening in the national cancer institute Li\u2013Fraumeni syndrome cohort. JAMA Oncol. 3, 1640\u20131645. https:\/\/doi.org\/10.1001\/jamaoncol.2017.1350 (2017).","journal-title":"JAMA Oncol."},{"key":"67810_CR40","doi-asserted-by":"publisher","first-page":"100265","DOI":"10.1016\/j.lana.2022.100265","volume":"12","author":"IA Frankenthal","year":"2022","unstructured":"Frankenthal, I. A., Alves, M. C., Tak, C. & Achatz, M. I. Cancer surveillance for patients with Li\u2013Fraumeni syndrome in Brazil: A cost-effectiveness analysis. Lancet Reg. Health Am. 12, 100265. https:\/\/doi.org\/10.1016\/j.lana.2022.100265 (2022).","journal-title":"Lancet Reg. Health Am."},{"key":"67810_CR41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/humu.24152","volume":"42","author":"C Fortuno","year":"2021","unstructured":"Fortuno, C. et al. Specifications of the ACMG\/AMP variant interpretation guidelines for germline TP53 variants. Human Mutat. 42, 223\u2013236. https:\/\/doi.org\/10.1002\/humu.24152 (2021).","journal-title":"Human Mutat."},{"key":"67810_CR42","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1016\/j.bbagen.2012.12.004","volume":"830","author":"EO Berge","year":"1830","unstructured":"Berge, E. O., Huun, J., Lillehaug, J. R., Lonning, P. E. & Knappskog, S. Functional characterisation of p53 mutants identified in breast cancers with suboptimal responses to anthracyclines or mitomycin. Biochim. Biophys. Acta 830, 2790\u20132797. https:\/\/doi.org\/10.1016\/j.bbagen.2012.12.004 (1830).","journal-title":"Biochim. Biophys. Acta"},{"key":"67810_CR43","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1158\/1541-7786.MCR-10-0496","volume":"9","author":"P Monti","year":"2011","unstructured":"Monti, P. et al. Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes. Mol. Cancer Res. 9, 271\u2013279. https:\/\/doi.org\/10.1158\/1541-7786.MCR-10-0496 (2011).","journal-title":"Mol. Cancer Res."},{"key":"67810_CR44","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1158\/1541-7786.MCR-09-0442","volume":"8","author":"JJ Jordan","year":"2010","unstructured":"Jordan, J. J. et al. Altered-function p53 missense mutations identified in breast cancers can have subtle effects on transactivation. Mol. Cancer Res. 8, 701\u2013716. https:\/\/doi.org\/10.1158\/1541-7786.MCR-09-0442 (2010).","journal-title":"Mol. Cancer Res."},{"key":"67810_CR45","doi-asserted-by":"publisher","first-page":"6976","DOI":"10.1038\/sj.onc.1208839","volume":"24","author":"T Kawaguchi","year":"2005","unstructured":"Kawaguchi, T. et al. The relationship among p53 oligomer formation, structure and transcriptional activity using a comprehensive missense mutation library. Oncogene 24, 6976\u20136981. https:\/\/doi.org\/10.1038\/sj.onc.1208839 (2005).","journal-title":"Oncogene"},{"key":"67810_CR46","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.canlet.2005.12.039","volume":"245","author":"MI Achatz","year":"2007","unstructured":"Achatz, M. I. et al. The TP53 mutation, R337H, is associated with Li\u2013Fraumeni and Li\u2013Fraumeni-like syndromes in Brazilian families. Cancer Lett. 245, 96\u2013102. https:\/\/doi.org\/10.1016\/j.canlet.2005.12.039 (2007).","journal-title":"Cancer Lett."},{"key":"67810_CR47","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/s41416-022-02059-z","volume":"128","author":"AB Abildgaard","year":"2023","unstructured":"Abildgaard, A. B. et al. Lynch syndrome, molecular mechanisms and variant classification. Br. J. Cancer 128, 726\u2013734. https:\/\/doi.org\/10.1038\/s41416-022-02059-z (2023).","journal-title":"Br. J. Cancer"},{"key":"67810_CR48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12896-015-0162-8","volume":"15","author":"K Motohashi","year":"2015","unstructured":"Motohashi, K. A simple and efficient seamless DNA cloning method using SLiCE from Escherichia coli laboratory strains and its application to SLiP site-directed mutagenesis. BMC Biotechnol. 15, 47. https:\/\/doi.org\/10.1186\/s12896-015-0162-8 (2015).","journal-title":"BMC Biotechnol."},{"key":"67810_CR49","first-page":"103","volume":"22","author":"WG Dirks","year":"2005","unstructured":"Dirks, W. G., Faehnrich, S., Estella, I. A. & Drexler, H. G. Short tandem repeat DNA typing provides an international reference standard for authentication of human cell lines. Altex 22, 103\u2013109 (2005).","journal-title":"Altex"},{"key":"67810_CR50","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1006\/abio.1976.9999","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248\u2013254. https:\/\/doi.org\/10.1006\/abio.1976.9999 (1976).","journal-title":"Anal. Biochem."},{"key":"67810_CR51","doi-asserted-by":"publisher","first-page":"10810","DOI":"10.1158\/0008-5472.CAN-05-0729","volume":"65","author":"ST Al Rashid","year":"2005","unstructured":"Al Rashid, S. T. et al. Evidence for the direct binding of phosphorylated p53 to sites of DNA breaks in vivo. Cancer Res. 65, 10810\u201310821. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-0729 (2005).","journal-title":"Cancer Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67810-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67810-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67810-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T23:15:19Z","timestamp":1722035719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-67810-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,26]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["67810"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-67810-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,26]]},"assertion":[{"value":"25 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17187"}}